| Catalog number | Packaging | |
|---|---|---|
| 144 | 1 Bottle x 100 mL | |
| 145 | 1 Bottle x 500 mL |
AfterFree is an ancillary material intended for use in the research, development, and manufacturing of cell- and gene-based therapeutic products, and is used to:
Thaw mesenchymal stem cells and other sensitive cell types while maintaining post-thaw cell viability.
Reduce osmotic shock and minimize cell membrane damage following DMSO removal.
The product is not intended for use as a drug, infusion solution, or for direct administration to humans or animals.
AfterFree is a cell thawing solution developed to reduce osmotic shock and enhance cell survival following cryopreservation and thawing. The product is supplied as a 1×, ready-to-use formulation, does not contain animal-derived proteins, and is suitable for use with mesenchymal stem cell lines and other sensitive cell types after thawing.
| Specification | Value |
|---|---|
| Visual appearance | Colorless, clear |
| Volume (mL) | 500 (± 5) mL (for 500 mL presentation); 100 (± 1) mL (for 100 mL presentation) |
| Sterility | Negative |
| Mycoplasma | Negative |
| Endotoxin | ≤ 0.25 EU/mL |
| Post-thaw viability of mesenchymal stem cells (UCMSC, ADSC) after 7 days of cryopreservation at -86 °C or -196 °C using MSCCryosave OTS | Post-thaw cell viability ≥ 75% |
Biomedmart - VNUHCM-US Stem Cell Institute